Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Edoxaban plasma concentration and coagulation in healthy volunteers
NCT03666650Phase 4Completed
- Sponsor
- Turku University Hospital
- Start
- Nov 2018
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of edoxaban in venous thromboembolism (VTE), Atrial fibrillation (AFib), sponsored by Turku University Hospital. Started Nov 2018; status: completed.
02
Drugs
edoxaban
03
Conditions
venous thromboembolism (VTE)Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03666650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03666650.